Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Crescent Capital BDC (FCRX) Return on Sales (2021 - 2025)

Historic Return on Sales for Crescent Capital BDC (FCRX) over the last 5 years, with Q3 2025 value amounting to 0.42%.

  • Crescent Capital BDC's Return on Sales fell 500.0% to 0.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42%, marking a year-over-year decrease of 500.0%. This contributed to the annual value of 0.46% for FY2024, which is 0.0% changed from last year.
  • According to the latest figures from Q3 2025, Crescent Capital BDC's Return on Sales is 0.42%, which was down 500.0% from 0.4% recorded in Q2 2025.
  • In the past 5 years, Crescent Capital BDC's Return on Sales registered a high of 0.59% during Q2 2022, and its lowest value of 2.26% during Q3 2021.
  • For the 5-year period, Crescent Capital BDC's Return on Sales averaged around 0.29%, with its median value being 0.46% (2023).
  • Its Return on Sales has fluctuated over the past 5 years, first surged by 28100bps in 2022, then tumbled by -1400bps in 2023.
  • Over the past 5 years, Crescent Capital BDC's Return on Sales (Quarter) stood at 2.26% in 2021, then skyrocketed by 121bps to 0.47% in 2022, then decreased by -2bps to 0.46% in 2023, then dropped by -4bps to 0.44% in 2024, then fell by -6bps to 0.42% in 2025.
  • Its Return on Sales stands at 0.42% for Q3 2025, versus 0.4% for Q2 2025 and 0.41% for Q1 2025.